Literature DB >> 23354793

The prognostic value of tumor-stroma proportion in laryngeal squamous cell carcinoma.

Mehtat Ünlü1, Hasan Oğuz Cetınayak, Devrim Onder, Cenk Ecevıt, Fadime Akman, Ahmet Ömer Ikız, Emel Ada, Bilge Karaçali, Sülen Sarioğlu.   

Abstract

OBJECTIVE: Tumor-stroma proportion of tumor has been presented as a prognostic factor in some types of adenocarcinomas, but there is no information about squamous cell carcinomas and laryngeal carcinomas. MATERIAL AND
METHOD: Five digital images of the tumor sections were obtained from 85 laryngeal carcinomas. Proportion of epithelial tumor component and stroma were measured by a software tool, allowing the pathologists to mark 205.6 μm2 blocks on areas as carcinomatous/stromal, by clicking at the image. Totally, 3.451 mm2 tumor areas have been marked to 16.785 small square blocks for each case.
RESULTS: Median follow up was 48 months (range 3-194). The mean tumor-stroma proportion was 48.63+18.18. There was no difference for tumor-stroma proportion when tumor location, grade, stage and perinodal invasion were considered. Although the following results were statistically insignificant, the mean tumor-stroma proportion was the lowest (37.46±12.49) for subglottic carcinomas, and it was 52.41±37.47, 50.86+19.84 and 44.56±16.91 for supraglottic, transglottic and glottic cases. The tumor-stroma proportion was lowest in cases with perinodal invasion and the highest in cases without lymph node metastasis (44.72±20.23, 47.77±17.37, 50.05±17.34). Tumor-stroma proportion was higher in the basaloid subtype compared with the classical squamous cell carcinoma (53.76±14.70 and 48.63±18.38 respectively). The overall and disease-free survival analysis did not reveal significance for tumor-stroma proportion (p=0.08, p=0.38). Only pathological stage was an independent factor for overall survival (p=0.008).
CONCLUSION: This is the first series investigating tumor-stroma proportion as a prognostic marker in laryngeal carcinomas proposing a new method, but the findings do not support tumor-stroma proportion as a prognostic marker.

Entities:  

Mesh:

Year:  2013        PMID: 23354793     DOI: 10.5146/tjpath.2013.01144

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  4 in total

1.  Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review.

Authors:  E-F Morais; H-G Morais; H-D Martins; L-M Carlan; A-D Costa; R-D Freitas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-07-01

Review 2.  The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns.

Authors:  Gemma Garcia-Vicién; Artur Mezheyeuski; María Bañuls; Núria Ruiz-Roig; David G Molleví
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

3.  Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations.

Authors:  G W van Pelt; S Kjær-Frifeldt; J H J M van Krieken; R Al Dieri; H Morreau; R A E M Tollenaar; F B Sørensen; W E Mesker
Journal:  Virchows Arch       Date:  2018-07-20       Impact factor: 4.064

4.  The prognostic value of tumor budding in laryngeal squamous cell carcinoma.

Authors:  Heng Zhang; Xiaoli Sheng; Siyi Zhang; Xia Gu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.